| Title | Clinical Biochemist Reviews |
| Abbreviation | Clin. Biochem. Rev. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Clinical Biochemistry (Q3) |
| h-index | 36 |
| Overall Rank/Ranking | 10837 |
| SCImago Journal Rank (SJR) | 0.497 |
| Impact Score | 4.00 |
| Publisher | Australasian Association of Clinical Biochemists |
| Country | Australia |
| ISSN | 1598090 |
| Best Quartile | Q3 |
| Coverage History | 2005, 2011-2021 |
Clinical Biochemist Reviews is a journal covering the technologies/fields/categories related to Clinical Biochemistry (Q3). It is published by Australasian Association of Clinical Biochemists. The overall rank of Clinical Biochemist Reviews is 10837. According to SCImago Journal Rank (SJR), this journal is ranked 0.497. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 36. The best quartile for this journal is Q3.
The ISSN of Clinical Biochemist Reviews journal is 1598090. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical Biochemist Reviews is cited by a total of 30 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Clinical Biochemist Reviews is 4.00, which is computed in 2024 as per its definition. Clinical Biochemist Reviews IF is increased by a factor of 0.3 and approximate percentage change is 8.11% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Clinical Biochemist Reviews is 4.00. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.00 |
| 2022 | 3.70 |
| 2021 | 6.86 |
| 2020 | 4.05 |
| 2019 | 4.41 |
| 2018 | 2.54 |
| 2017 | 0.82 |
| 2016 | 2.14 |
| 2015 | 3.06 |
| 2014 | 3.00 |
Clinical Biochemist Reviews has an h-index of 36. It means 36 articles of this journal have more than 36 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Clinical Biochemist Reviews is 1598090. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Clinical Biochemist Reviews is 10837. According to SCImago Journal Rank (SJR), this journal is ranked 0.497. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.497 |
| 2022 | 1.264 |
| 2021 | 1.222 |
| 2020 | 1.132 |
| 2019 | 0.871 |
| 2018 | 0.470 |
| 2017 | 0.434 |
| 2016 | 0.913 |
| 2015 | 0.773 |
| 2014 | 1.351 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 10837 |
| 2022 | 2843 |
| 2021 | 2973 |
| 2020 | 3624 |
| 2019 | 5291 |
| 2018 | 10002 |
| 2017 | 10292 |
| 2016 | 4964 |
| 2015 | 6142 |
| 2014 | 2727 |
Clinical Biochemist Reviews is published by Australasian Association of Clinical Biochemists. It's publishing house is located in Australia. Coverage history of this journal is as following: 2005, 2011-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Clinical Biochemist Reviews is Clin. Biochem. Rev.. This abbreviation ('Clin. Biochem. Rev.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Clinical Biochemistry (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Clinical Biochemist Reviews latest impact IF is 4.00. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 6.86 (2021) and 0.82 (2017), respectively, in the last 10 years. Moreover, its average IS is 3.46 in the previous 10 years.
The Clinical Biochemist Reviews has an SJR (SCImago Journal Rank) of 0.497, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.351 in 2014 and the lowest being 0.434 in 2017. Furthermore, the average SJR of the Clinical Biochemist Reviews over the previous 10-year period stands at 3.46.
The latest h-index of the Clinical Biochemist Reviews is 36.
The Clinical Biochemist Reviews is published by the Australasian Association of Clinical Biochemists, with its country of publication being the Australia.
The Clinical Biochemist Reviews is currently ranked 10837 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 2727 in 2014 and its lowest position of 10837 in 2023.
The standard ISO4 abbreviation for the Clinical Biochemist Reviews is Clin. Biochem. Rev..
Clinical Biochemist Reviews is classified as a journal that the Australasian Association of Clinical Biochemists publishes.
The Clinical Biochemist Reviews encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Clinical Biochemist Reviews is assigned the following International Standard Serial Numbers (ISSN): 1598090.
The best quartile for the Clinical Biochemist Reviews is Q3 (2023).
The Clinical Biochemist Reviews coverage history can be summarized as follows: 2005, 2011-2021.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Supply Chain Management | journal | 587 | Wiley-Blackwell | 112 | 12.51 |
| Discourse | journal | 6196 | Routledge | 65 | 2.36 |
| Child and Family Social Work | journal | 8089 | Wiley-Blackwell Publishing Ltd | 75 | 2.10 |
| Journal of Education and Work | journal | 11494 | Brill Academic Publishers | 45 | 2.17 |
| Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
| Museum Management and Curatorship | journal | 10406 | Routledge | 40 | 1.72 |
| Journal des Professionnels de l'Enfance | journal | 28748 | TPMA | 2 | 0.00 |
| Transboundary and Emerging Diseases | journal | 5087 | 84 | 3.59 | |
| HOMO- Journal of Comparative Human Biology | journal | 20265 | Elsevier B.V. | 38 | 0.79 |
| Journal of Medical Toxicology | journal | 7459 | Springer New York | 58 | 1.58 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.00 |
| 2022 | 3.70 |
| 2021 | 6.86 |
| 2020 | 4.05 |
| 2019 | 4.41 |
| 2018 | 2.54 |
| 2017 | 0.82 |
| 2016 | 2.14 |
| 2015 | 3.06 |
| 2014 | 3.00 |
